We are live on ! Find out more
DA

DSC Advisors Portfolio holdings

AUM $11M
1-Year Est. Return 5.88%
This Fund
S&P 500
This Quarter Est. Return
+9.3%
1 Year Est. Return
+5.88%
3 Year Est. Return
+3.18%
5 Year Est. Return
+39.43%
10 Year Est. Return
+114.64%
AUM
$129M
AUM Growth
+$31M
Cap. Flow
+$24.2M
Cap. Flow %
18.73%
Top 10 Hldgs %
72.18%
Holding
83
New
11
Increased
21
Reduced
34
Closed
13

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$5.78M
2
ZBH icon
Zimmer Biomet
ZBH
+$5.47M
3
VYNE icon
VYNE Therapeutics
VYNE
+$1.73M
4
GENI icon
Genius Sports
GENI
+$674K
5
HYRE
HyreCar Inc. Common Stock
HYRE
+$594K

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$5.43M
2
EHTH icon
eHealth
EHTH
+$1.66M
3
X
US Steel
X
+$769K
4
COMS
COMSovereign Holding Corp. Common Stock
COMS
+$725K
5
RTX icon
RTX Corp
RTX
+$284K

Sector Composition

Rank Sector Weight
1 Healthcare 32.19%
2 Technology 9.61%
3 Communication Services 9.37%
4 Financials 9.33%
5 Consumer Discretionary 2.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RTX icon
76
RTX Corp
RTX
$261B
– –
-3,302
Closed -$284K
SLV icon
77
CALL
iShares Silver Trust
SLV
$27.1B
– –
-25,000
Closed -$513K
SPY icon
78
State Street SPDR S&P 500 ETF Trust
SPY
$774B
– –
-21
Closed -$9K
SPY icon
79
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$774B
– –
-31,500
Closed -$13.5M
X
80
CALL
DELISTED
US Steel
X
– –
-20,000
Closed -$439K
X
81
DELISTED
US Steel
X
– –
-35,000
Closed -$769K
COMSW
82
DELISTED
COMSovereign Holding Corp. Warrants
COMSW
– –
-230,000
Closed -$101K
COMS
83
DELISTED
COMSovereign Holding Corp. Common Stock
COMS
– –
-4,500
Closed -$725K
1 2 3
4

Similar funds

RJTCONH
Raymond James Trust Company of New Hampshire Portsmouth, New Hampshire $12.1M AUM 28.84% 1-Year Est. Return
HSC
Harbor Spring Capital New York $12.3M AUM
BGC
Birch Grove Capital New York $9.51M AUM 0.22% 1-Year Est. Return
ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
AG
Arctis Global San Juan, Puerto Rico $14.5M AUM 58.16% 1-Year Est. Return
RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
JDR
Jay D. Rosenbaum $6.69M AUM 4.68% 1-Year Est. Return
KM
Kabouter Management Chicago, Illinois $15.6M AUM 16.79% 1-Year Est. Return

DSC Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, DSC Advisors held 83 positions worth $129M, up 31% from $98.5M the previous quarter. Its ten largest holdings account for 72% of the portfolio.

DSC Advisors deployed $24.2M of net new capital in Q4 2021, opening 11 new positions and adding to 21 existing holdings. Its largest new stake was BioMarin Pharmaceuticals: 70,000 shares worth $6.18M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 32% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was eHealth, an estimated $1.66M trimmed.

  • DSC Advisors's largest Q4 2021 buy was BioMarin Pharmaceuticals: 70,000 shares worth $6.18M.
  • DSC Advisors added most to VYNE Therapeutics in Q4 2021, an estimated $1.73M increase.
  • DSC Advisors's biggest Q4 2021 reduction was eHealth, cutting an estimated $1.66M.
  • DSC Advisors fully exited Bristol-Myers Squibb in Q4 2021, selling an estimated $5.43M.
  • DSC Advisors's ten largest holdings make up 72% of its $129M portfolio in Q4 2021.
  • DSC Advisors opened 11 new positions and closed 13 in Q4 2021.
  • DSC Advisors's portfolio value rose 31% quarter-over-quarter to $129M.

Based on DSC Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.